시장보고서
상품코드
1765127

세계의 비혈관 스텐트 시장

Non-Vascular Stents

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

비혈관 스텐트 세계 시장은 2030년까지 22억 달러에 이를 전망

2024년에 16억 달러로 추정되는 비혈관 스텐트 세계 시장은 2024-2030년 CAGR 5.1%로 성장하여 2030년에는 22억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 비뇨기과 스텐트는 CAGR 5.1%를 나타내고, 분석 기간 종료까지 11억 달러에 이를 것으로 예측됩니다. 소화기 스텐트 부문의 성장률은 분석 기간중 CAGR 5.3%로 추정됩니다.

미국 시장은 4억 4,590만 달러로 추정, 중국은 CAGR4.9%로 성장 예측

미국의 비혈관 스텐트 시장은 2024년에는 4억 4,590만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 3억 4,730만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 4.9%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 4.8%와 4.4%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.8%를 보일 전망입니다.

세계 비혈관 스텐트 시장 - 주요 동향 및 촉진요인 정리

비혈관 스텐트란 무엇이며, 왜 환자 치료에 필수적인가?

비혈관 스텐트는 소화기, 비뇨기, 호흡기 등 비혈관 계통의 통로를 지지하고 개방된 상태로 유지하는 데 사용되는 의료기기입니다. 이 스텐트는 주로 식도, 담관, 요관, 기도 등 장기의 종양, 협착 및 기타 막힘으로 인한 막힘을 치료하는 데 사용됩니다. 동맥이나 정맥에 사용되는 혈관 스텐트와 달리 비혈관 스텐트는 연조직 장기의 막힘을 완화하고 호흡, 배뇨, 소화 등 정상적인 신체 기능을 유지하는 데 중점을 둡니다. 비혈관 스텐트에 사용되는 재료는 금속 합금에서 생분해성 폴리머에 이르기까지 다양하여 환자의 특정 상태에 따라 맞춤형 솔루션을 제공할 수 있습니다. 비혈관 스텐트의 사용은 이러한 시스템의 막힘으로 인해 암 환자의 완화 치료에서 점점 더 중요해지고 있습니다.

기술의 발전은 비혈관 스텐트 시장에 어떤 혁명을 불러일으키고 있을까요?

비혈관 스텐트 시장은 최근 첨단 소재와 스텐트 디자인의 개발로 인해 큰 혁신을 이루고 있습니다. 일정 기간이 지나면 용해되는 생분해성 스텐트는 스텐트 제거를 위한 재수술의 필요성을 줄일 수 있어 인기를 끌고 있습니다. 또한, 스텐트 주변 조직의 염증과 증식을 방지하기 위해 약물을 천천히 방출하는 약물 용출성 스텐트도 널리 채택되고 있습니다. 스텐트의 유연성 향상과 자가 확장형 스텐트의 개발로 시술이 쉬워지고 시술의 위험도 감소했습니다. 이러한 기술의 발전은 폐색에 대한 치료를 보다 정확하고 최소 침습적으로 진행하여 환자의 결과와 회복 시간을 개선합니다. 최소침습 수술이 대중화됨에 따라 비혈관 스텐트는 다양한 증상, 특히 침습적 수술에 적합하지 않은 환자들의 다양한 증상에 대한 해결책으로 점점 더 많이 도입되고 있습니다.

인구통계학적 요인과 헬스케어 트렌드가 비혈관 스텐트 시장에 어떤 영향을 미치고 있는가?

암, 위장병, 만성폐쇄성폐질환(COPD) 등의 질병 발병률 증가는 비혈관 스텐트 수요를 견인하는 주요 요인 중 하나입니다. 전 세계적으로 고령화가 진행되면서 담도, 비뇨기, 호흡기 질환의 유병률이 증가하고 있습니다. 이러한 인구통계학적 변화로 인해 완화 치료와 근치적 치료 모두에서 스텐트 삽입술에 대한 수요가 지속적으로 증가하고 있습니다. 또한, 특히 신흥 시장에서 의료 인프라의 발전으로 비혈관 스텐트와 같은 의료기기에 대한 접근성이 확대되고 있으며, 이전에는 의료 서비스가 제공되지 않았던 지역에서 의료 기술 채택이 증가하고 있습니다. 또한, 특히 종양학 분야에서 환자의 편안함과 삶의 질에 대한 관심이 높아지면서 폐색으로 인한 증상 완화를 위한 솔루션으로 비혈관 스텐트에 대한 의존도가 높아지고 있습니다.

비혈관 스텐트 시장의 성장을 가속하는 요인은 무엇인가?

비혈관 스텐트 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 자가 확장형 스텐트 및 약물 용출형 스텐트의 개발과 같은 기술적 발전으로 인해 치료 결과가 개선되고 합병증이 감소함에 따라 이러한 장치가 널리 채택되고 있습니다. 또한, 암과 만성질환의 유병률 증가, 특히 고령화 사회로의 진입은 완화 치료에 필수적인 비혈관 스텐트에 대한 수요를 촉진하고 있습니다. 또한, 저침습 수술로의 전환은 특히 고령자 및 중증 환자에서 침습적인 수술 방법보다 스텐트 채택을 촉진하고 있습니다. 신흥 시장의 의료 접근성 확대와 의료 인프라에 대한 투자 확대는 비혈관 스텐트 시장에 새로운 기회를 제공합니다. 마지막으로, 특정 환자의 필요에 따라 스텐트를 맞춤 설계하는 개인 맞춤형 의료 트렌드가 시장 성장을 더욱 촉진하고 있습니다.

부문

제품 유형(비뇨기용 스텐트, 소화관용 스텐트, 폐용 스텐트, 기타 제품 유형)

조사 대상 기업 예

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.07.16

Global Non-Vascular Stents Market to Reach US$2.2 Billion by 2030

The global market for Non-Vascular Stents estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Gastrointestinal Stents segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.9 Million While China is Forecast to Grow at 4.9% CAGR

The Non-Vascular Stents market in the U.S. is estimated at US$445.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.3 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Non-Vascular Stents Market - Key Trends & Drivers Summarized

What Are Non-Vascular Stents and Why Are They Crucial for Patient Care?

Non-vascular stents are medical devices used to support and keep open passageways in non-vascular systems, such as the digestive, urinary, and respiratory tracts. These stents are primarily used to treat obstructions caused by tumors, strictures, or other blockages in organs such as the esophagus, bile ducts, ureters, and airways. Unlike vascular stents, which are used in arteries and veins, non-vascular stents focus on relieving obstructions in soft tissue organs, ensuring normal bodily functions like breathing, urination, or digestion are maintained. Materials used for non-vascular stents range from metal alloys to biodegradable polymers, allowing for tailored solutions based on the patient’s specific condition. The use of non-vascular stents has become increasingly important in palliative care for patients with cancers that lead to blockages in these systems.

How Are Technological Advancements Revolutionizing the Non-Vascular Stents Market?

The non-vascular stents market has seen significant innovation in recent years, particularly with the development of advanced materials and stent designs. Biodegradable stents, which dissolve after a certain period, are gaining traction as they reduce the need for repeat procedures to remove the stent. Additionally, drug-eluting stents, which slowly release medication to prevent tissue inflammation or growth around the stent, are becoming more widely adopted. Improvements in stent flexibility and the development of self-expanding stents have enhanced the ease of implantation and reduced procedural risks. These technological advancements allow for more precise and less invasive treatment of blockages, improving patient outcomes and recovery times. As minimally invasive procedures gain popularity, non-vascular stents are increasingly being deployed as a solution for a range of conditions, particularly in patients who are not ideal candidates for more invasive surgeries.

How Are Demographic and Healthcare Trends Impacting the Non-Vascular Stents Market?

The rising incidence of diseases such as cancer, gastrointestinal disorders, and chronic obstructive pulmonary disease (COPD) is one of the primary drivers of demand for non-vascular stents. With aging populations across the globe, there is an increasing prevalence of conditions that lead to obstructions in the biliary, urinary, and respiratory tracts. This demographic shift is creating sustained demand for stenting procedures as part of both palliative and curative care. Moreover, advancements in healthcare infrastructure, particularly in emerging markets, have expanded access to medical devices such as non-vascular stents, increasing their adoption in regions previously underserved by medical technology. Additionally, the growing emphasis on patient comfort and quality of life, particularly in oncology, has led to a greater reliance on non-vascular stents as a solution to alleviate symptoms caused by obstructions.

What Factors Are Driving Growth in the Non-Vascular Stents Market?

The growth in the non-vascular stents market is driven by several factors. Technological advancements, such as the development of self-expanding and drug-eluting stents, are enhancing treatment outcomes and reducing complications, which in turn is driving wider adoption of these devices. The increasing prevalence of cancer and chronic diseases, particularly in aging populations, is also fueling demand for non-vascular stents as an essential part of palliative care. Furthermore, the shift toward minimally invasive procedures is driving the adoption of stents over more invasive surgical options, particularly for elderly patients or those with severe conditions. Expanding healthcare access in emerging markets, combined with growing investments in medical infrastructure, is opening up new opportunities for the non-vascular stents market. Finally, the trend toward personalized medicine, with customized stent designs for specific patient needs, is further bolstering market growth.

SCOPE OF STUDY:

The report analyzes the Non-Vascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Urology Stents, Gastrointestinal Stents, Pulmonary Stents, Other Product Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Non-Vascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Gastrointestinal Disorders Drives Demand for Non-Vascular Stents in Endoscopic Procedures
    • Increasing Adoption of Urological Stents Expands Market for Non-Vascular Solutions in Kidney and Urinary Tract Treatments
    • Growing Use of Biliary Stents Fuels Market Growth in the Treatment of Bile Duct Obstructions and Gallstones
    • Technological Advancements in Self-Expanding Stents Propel Growth in Non-Vascular Applications for Digestive Health
    • Rising Demand for Non-Vascular Stents in Colorectal Cancer Treatment Expands Market for Minimally Invasive Oncology Solutions
    • Increasing Use of Pancreatic Stents Strengthens Market for Non-Vascular Stents in Gastrointestinal Surgeries
    • Emerging Focus on Non-Vascular Stents for Airway Management Fuels Growth in Respiratory and Pulmonary Applications
    • Rising Adoption of Non-Vascular Stents in Palliative Care Expands Opportunities for End-of-Life Interventions
    • Growing Demand for Non-Vascular Stents in Pediatric Patients Expands Market for Specialized Stenting Solutions
    • Technological Innovations in Biodegradable and Drug-Eluting Non-Vascular Stents Propel Growth in Long-Term Treatment Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-Vascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urology Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Gastrointestinal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CHINA
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of World 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제